Exploring Facilitators and Barriers to Delayed Antibiotic Prescribing in Rural Northwest China: A Qualitative Study Using the Theoretical Domains Framework and Behavior Change Wheel

被引:0
|
作者
Wushouer, Haishaerjiang [1 ,2 ]
Ko, Weihsin [1 ]
Du, Kexin [1 ]
Zhang, Wanmeng [1 ]
Hu, Lin [1 ]
Yu, Junxuan [1 ]
Zhang, Kairui [1 ]
Shi, Luwen [1 ,2 ]
Guan, Xiaodong [1 ,2 ]
机构
[1] Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100191, Peoples R China
[2] Peking Univ, Int Res Ctr Med Adm, Beijing 100191, Peoples R China
来源
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 12期
基金
中国国家自然科学基金;
关键词
delayed antibiotic prescribing; antibiotic use; Theoretical Domains Framework; Behavior Change Wheel;
D O I
10.3390/antibiotics12121741
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Antimicrobial resistance, exacerbated by antibiotic misuse, poses a global threat. Though delayed antibiotic prescribing (DAP) can mitigate antibiotic overuse, its adoption in developing nations, such as China, is limited. This study probed barriers and facilitators to DAP in Xinjiang, characterized by extensive rural landscapes and primary care institutions (PCIs). Methods: Adopting a qualitative methodology, we conducted key informant interviews with thirty participants across six county hospitals in Xinjiang using VooV Meeting. Employing a two-stage sampling method targeting economically diverse areas, our interviews spanned physicians, pharmacists, patients, and caregivers. We organized the data according to the Theoretical Domains Framework (TDF) and the Behavior Change Wheel (BCW), spotlighting behavioral and policy elements impacting DAP. Results: Our research included thirty interviewees. Twelve physicians contemplated delayed prescriptions, while five adult patients and six caregivers encountered recommendations for delayed antibiotic prescriptions. Six patients sought pharmacists' advice on antibiotic necessity. Prominent TDF domains were memory, attention, and beliefs about consequences. Critical intervention functions included education and environmental restructuring, while vital policy categories encompassed communication/marketing and guidelines. Conclusions: Countering antibiotic misuse and resistance in China necessitates overcoming barriers through strategic resource distribution, comprehensive education, rigorous training, and consistent monitoring, thereby promoting DAP adoption. The adoption of DAP in rural healthcare settings in China has the potential to significantly reduce antibiotic misuse, thereby mitigating the global threat of antimicrobial resistance.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Using theory to explore facilitators and barriers to delayed prescribing in Australia: a qualitative study using the Theoretical Domains Framework and the Behaviour Change Wheel
    Lucy Sargent
    Amanda McCullough
    Chris Del Mar
    John Lowe
    BMC Family Practice, 18
  • [2] Using theory to explore facilitators and barriers to delayed prescribing in Australia: a qualitative study using the Theoretical Domains Framework and the Behaviour Change Wheel
    Sargent, Lucy
    McCullough, Amanda
    Del Mar, Chris
    Lowe, John
    BMC FAMILY PRACTICE, 2017, 18
  • [3] A qualitative evidence synthesis (QES) exploring the barriers and facilitators to screening in emergency departments using the theoretical domains framework
    Barry, Louise
    Tighe, Sylvia Murphy
    Griffin, Anne
    Ryan, Damien
    O'Connor, Margaret
    Fitzgerald, Christine
    Egan, Siobhan
    Galvin, Rose
    Meskell, Pauline
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [4] A qualitative evidence synthesis (QES) exploring the barriers and facilitators to screening in emergency departments using the theoretical domains framework
    Louise Barry
    Sylvia Murphy Tighe
    Anne Griffin
    Damien Ryan
    Margaret O’Connor
    Christine Fitzgerald
    Siobhan Egan
    Rose Galvin
    Pauline Meskell
    BMC Health Services Research, 23
  • [5] Determinants of antibiotic prescribing in primary care in Vietnam: a qualitative study using the Theoretical Domains Framework
    Minh, Duy Vu
    Hong, Yen Nguyen Thi
    Nagraj, Shobhana
    Thuy, Nga Do Thi
    Lan, Huong Vu Thi
    Vinh, Nam Nguyen
    Cam, Tu Nguyen Thi
    Hai, Yen Nguyen
    Thien, Huong Cai Ngoc
    Thi, Hang Tran
    Yen, Nhi Nguyen
    Alban, Hannah
    Thanh, Vinh Khuong
    Thanh, Huyen Duong Thi
    Huy, Hoang Tran
    Nuil, Jennifer Van
    Lewycka, Sonia
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2024, 13 (01):
  • [6] A systematic review using the Theoretical Domains Framework to identify barriers and facilitators to the adoption of prescribing guidelines
    Paksaite, Paulina
    Crosskey, Joel
    Sula, Eni
    West, Celine
    Watson, Margaret
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2021, 29 (01) : 3 - 11
  • [7] Barriers and facilitators to discussing HPV with head and neck cancer patients: A qualitative study using the theoretical domains framework
    O'Connor, M.
    Waller, J.
    Gallagher, P.
    O'Donovan, B.
    Clarke, N.
    Keogh, I.
    MacCarthy, D.
    O'Sullivan, E.
    Timon, C.
    Martin, C.
    O'Leary, J.
    Sharp, L.
    PATIENT EDUCATION AND COUNSELING, 2020, 103 (12) : 2451 - 2459
  • [8] Barriers and facilitators to seeking psychological support among healthcare professionals: a qualitative study using the Theoretical Domains Framework
    Liu, Sha
    Hu, Yinhuan
    Pfaff, Holger
    Lei, Xiaoyun
    Qi, Zhen
    Feng, Xiandong
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [9] Barriers and facilitators to nursing delirium screening in older emergency patients: a qualitative study using the theoretical domains framework
    Eagles, Debra
    Cheung, Warren J.
    Avlijas, Tanja
    Yadav, Krishan
    Ohle, Robert
    Taljaard, Monica
    Molnar, Frank
    Stiell, Ian G.
    AGE AND AGEING, 2022, 51 (01)
  • [10] Barriers and facilitators to hospital pharmacists' engagement in medication safety activities: A qualitative study using the theoretical domains framework
    Mekonnen A.B.
    McLachlan A.J.
    Brien J.-A.E.
    Mekonnen D.
    Abay Z.
    Journal of Pharmaceutical Policy and Practice, 11 (1)